Brain Scientific
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Brain Scientific generated cash of -$5,935,070, which is less than the previous year. Cash used in financing activities reached the amount of $5,930,621 last year. Net change in cash is therefore -$37,649.
Cash Flow
| 2016 | -50 | 0 | 50 |
|---|---|---|---|
| 2017 | -873.64K | -1.95K | 1.13M |
| 2018 | -1.11M | -1.14K | 979.86K |
| 2019 | -854.72K | -1.00K | 953.23K |
| 2020 | -931.66K | -30.37K | 861.47K |
| 2021 | -5.86M | -58.64K | 6.64M |
| 2022 | -5.93M | -33.29K | 5.93M |
BRSF Cash Flow Statement (2016 – 2022)
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|
Cash at beginning of period | 785.36K | 68.94K | 261.43K | 163.56K | 297.52K | 160 | 0 |
Operating activities | |||||||
Net income | -12.34M | -9.10M | -2.80M | -1.00M | -1.42M | -958.28K | -50 |
| Adjustments to reconcile net income to cash generated by operating activities: | |||||||
Depreciation and amortization | 804.76K | 219.83K | 17.35K | 1.33K | 656 | 445 | 0 |
Stock-based compensation expense | 0 | 3.22K | 355 | 30 | 0 | 0 | 0 |
| Deferred income tax benefit | 0 | 3.22K | 355 | 30 | 0 | 0 | 0 |
| Changes in operating assets and liabilities: | |||||||
Accounts receivable, net | 15.97K | -1.57K | 4.09B | -5.55K | 0 | 0 | 0 |
Inventories | -3.46K | -99.37K | -44.90K | -7.08K | 0 | 1.16K | 0 |
Accounts payable | -365.90K | 112.50K | 1.50M | 136.80K | 213.98K | 43.94K | 50 |
Cash generated by operating activities | -5.93M | -5.86M | -931.66K | -854.72K | -1.11M | -873.64K | -50 |
Investing activities | |||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -33.29K | -58.64K | -30.37K | -1.00K | -1.14K | -1.95K | 0 |
Acquisitions Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | -33.29K | -58.64K | -30.37K | -1.00K | -1.14K | -1.95K | 0 |
Financing activities | |||||||
Common Stock Issued | 0 | 280.17K | 100K | 17.72B | 5.14K | 100K | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 5.93M | -574.13K | -761.47K | 0 | 0 | 1.03M | 0 |
Cash used in financing activities | 5.93M | 6.64M | 861.47K | 953.23K | 979.86K | 1.13M | 50 |
Net Change In Cash | -37.64K | 716.42K | -192.49K | 97.87K | -133.96K | 297.36K | 0 |
Cash at end of period | 747.71K | 785.36K | 68.94K | 261.43K | 163.56K | 297.52K | 0 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source |